Brief: Crispr Therapeutics Reports First Quarter 2023 Financial Results

Crispr Therapeutics AG

08/05/2023 23:16

May 8 (Reuters) - Crispr Therapeutics Ag  CRSP.BN :
    * CRISPR THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FIRST
QUARTER 2023 FINANCIAL RESULTS
    * QTRLY LOSS PER SHARE $0.67
    * Q2 EARNINGS PER SHARE VIEW $-1.95 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXGgvDx 
Further company coverage:  CRSP.BN 

 ((Reutersbriefs@thomsonreuters.com;))